One small study showed morning dosing may offer about 15% better post-prandial glucose control, but the more impactful consideration is whether morning or evening timing better manages your side effects and aligns with your routine
: Credits SUN PHARMA #pharmivonmedia #IndustryNews #SunPharma #DCGI #WeightLossTherapy #PharmaInnovation #IndianPharma #HealthcareNews #pharmacy #healthcare #pharmd #medical #industry To view or add a comment, sign in Indias pharma market continues to expand, reaching 2.4 lakh crore in 2025 and projecting ~8% growth in 2026
Because combination drug therapy is becoming more common in obesity treatment, this question is now asked more often
[57] A large randomized, controlled trial (PANTHER-IPF) was undertaken by the National Institutes of Health (NIH) in the US to evaluate triple therapy and NAC monotherapy in IPF patients
Cyanocobalamin: Tell your healthcare provider if you have kidney disease, megaloblastic anemia, pregnant or trying to get pregnant, or breast feeding
